Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study

Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Han, Seung Hyeok, Choi, Kyu Hun, Lee, Joongyub, Chae, Dong Wan, Oh, Kook-Hwan, Ahn, Curie, Kim, Soo Wan
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113973/
https://ncbi.nlm.nih.gov/pubmed/27855207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166792
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky